NPR’s Ailsa Chang talks to Eli Lilly CEO David Rix concerning the firm’s transfer to chop costs on some older insulins and restrict how a lot folks need to pay out of pocket.
Copyright © 2023 NPR. All rights reserved. Please go to the phrases of use and permissions pages of our web site at www.npr.org for extra info.
NPR transcripts are produced on a decent schedule by an NPR contractor. This textual content will not be in its ultimate type and could also be up to date or revised sooner or later. Accuracy and availability might differ. The official recording of NPR applications is an audio recording.
